MEDICINOVA INC (MNOV) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21
	10-Q	10-Q	10-Q	10-Q	10-Q	10-K	10-Q	10-Q
Total revenues		0.0	3.9		0.0	0.0	0.0	4.3
Revenue growth			10293.2%		-100.0%	-100.0%	-99.0%	-4.5%
Cost of goods sold		0.0	3.9		0.0	2.1	3.6	4.3
Gross profit		0.0	0.0		0.0	-2.1	-3.6	0.0
Gross margin			0.0%				-9605.2%	0.0%
Selling, general and administrative [+]		3.0	1.4		3.4	0.3	1.6	1.8
General and administrative			1.4			0.3	1.6	1.8
Other selling, general and administrative
Research and development
Other operating expenses		-3.0	2.5		-3.4	-0.3	-1.6	2.5
EBITDA [+]		0.0	-3.9		0.0	-2.1	-3.6	-4.3
EBITDA growth		-7.3%	8.3%		-102.3%	-30.3%	-3.5%	-4.5%
EBITDA margin			-99.9%				-9586.1%	-99.9%
Depreciation and amortization		0.0	0.0		0.0	0.0	0.0	0.0
EBIT [+]		0.0	-3.9		0.0	-2.1	-3.6	-4.3
EBIT growth			8.2%		-100.0%	-30.2%	-3.4%	-4.5%
EBIT margin			-100.0%				-9605.2%	-100.0%
Interest income		0.5	0.3		0.0	0.0	0.0	0.0
Interest income		0.5	0.3		0.0	0.0	0.0	0.0
Other income (expense), net [+]		-3.4	0.0		-3.4	0.0	0.0	0.0
Other			0.0			0.0	0.0	0.0
Pre-tax income		-2.9	-3.7		-3.4	-2.1	-3.6	-4.3
Income taxes		0.0	0.0		0.0	0.0	0.0	0.0
Tax rate		0.0%	0.0%		0.0%		0.0%	0.0%
Net income		-2.9	-3.7		-3.4	-2.1	-3.6	-4.3
Net margin			-93.7%				-9544.4%	-99.4%

Basic EPS [+]		($0.06)	($0.07)		($0.07)	($0.04)	($0.07)	($0.09)
Growth		-13.9%	1.9%		1647.8%	-36.2%	-11.9%	-13.0%
Diluted EPS [+]		($0.06)	($0.07)		($0.07)	($0.04)	($0.07)	($0.09)
Growth		-13.9%	1.9%		1647.8%	-36.2%	-11.9%	-13.0%

Shares outstanding (basic) [+]		49.0	49.0		49.0	48.6	49.0	48.8
Growth		0.0%	0.1%		3.2%	9.4%	9.7%	10.7%
Shares outstanding (diluted) [+]		49.0	49.0		49.0	48.6	49.0	48.8
Growth		0.0%	0.1%		3.2%	9.4%	9.7%	10.7%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.